Q3 2022 Holdings
Filed 2022-11-08 | 66 holdings | $40.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Black Diamond Therapeutic | COM | 0920E3105 | $75 | 44,000 | 0.0% |
| Mirum Pharmaceuticals Inc(MIRM) | COM | 604749101 | $193 | 9,219 | 0.0% |
| Albireo Pharma Inc(BDQM) | COM | 01345P106 | $312 | 16,093 | 0.0% |
| Madrigal Pharms.(MDGL) | COM | 558868105 | $348 | 5,350 | 0.0% |
| Relmada Therapeutics(RLMD) | COM | 75955J402 | $370 | 10,000 | 0.0% |
| Iovance Biotherapeutics(IOVA) | COM | 462260100 | $536 | 56,000 | 0.0% |
| Hutchmed China LTD(HCM) | SPONSORED ADS | 44842L103 | $602 | 68,000 | 0.0% |
| Ironwood Pharmaceuticals Inc(IRWD) | COM | 46333X108 | $621 | 60,000 | 0.0% |
| Insmed Inc(INSM) | COM | 457669307 | $864 | 40,100 | 0.0% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $918 | 25,500 | 0.0% |
| Rocket Pharms.(RCKT) | COM | 77313F106 | $1.0K | 63,000 | 0.0% |
| PTC Therapeutics(PTCT) | COM | 69366J200 | $1.1K | 21,000 | 0.0% |
| Denali Therapeutics(DNLI) | COM | 24823R105 | $1.2K | 38,000 | 0.0% |
| Intellia Therapeutics(NTLA) | COM | 45826J105 | $1.3K | 24,000 | 0.0% |
| Concert Pharmaceuticals Inc(CNCEEUR) | COM | 206022105 | $1.3K | 200,800 | 0.0% |
| Legend Biotech(LEGN) | SPONSORED ADS | 52490G102 | $1.6K | 38,000 | 0.0% |
| Fulcrum Therapeutics Inc(FULC) | COM | 359616109 | $1.6K | 193,741 | 0.0% |
| Ideaya Biosciences(IDYA) | COM | 45166A102 | $1.6K | 109,000 | 0.0% |
| I-Mab(NBP) | SPONSORED ADS | 44975P103 | $2.0K | 507,239 | 0.0% |
| Adicet BIO Inc(TORCEUR) | COM | 007002108 | $2.2K | 154,708 | 0.0% |
| Crispr Therapeutics AG(CRSP) | NAMEN AKT | H17182108 | $2.2K | 34,200 | 0.0% |
| Jazz Pharms.(JAZZ) | SHS USD | G50871105 | $2.3K | 17,200 | 0.0% |
| Novavax Inc(NVAX) | COM | 670002401 | $2.4K | 132,500 | 0.0% |
| Novocure LTD(NVCR) | ORD SHS | G6674U108 | $2.4K | 32,000 | 0.0% |
| Zai Lab Ltd ADR (V1 Ord)(ZLAB) | ADR | 98887Q104 | $2.7K | 78,958 | 0.0% |
| Fate Therapeutics(FATE) | COM | 31189P102 | $2.7K | 121,000 | 0.0% |
| United Therapeutics Corp del(VTRS) | COM | 92556V106 | $3.1K | 364,000 | 0.0% |
| Krystal Biotech(KRYS) | COM | 501147102 | $3.1K | 45,000 | 0.0% |
| United Therapeutics Corp del(UTHR) | COM | 91307C102 | $3.1K | 15,000 | 0.0% |
| Neurocrine Biosciences(NBIX) | COM | 64125C109 | $3.2K | 30,000 | 0.0% |
| Revance Therapeutics Inc(RVNCEUR) | COM | 761330109 | $3.2K | 120,000 | 0.0% |
| Amgen Inc COM(AMGN) | COM | 031162100 | $3.7K | 16,246 | 0.0% |
| Guardant Health(GH) | COM | 40131M109 | $4.0K | 74,500 | 0.0% |
| Dyne Therapeutics(DYN) | COM | 26818M108 | $4.4K | 350,068 | 0.0% |
| Travere Therapeutics Inc(TVTX) | COM | 89422G107 | $4.6K | 186,019 | 0.0% |
| Kalvista Pharms.(KALV) | COM | 483497103 | $4.6K | 316,133 | 0.0% |
| Illumina Inc(ILMN) | COM | 452327109 | $4.8K | 25,000 | 0.0% |
| Galapagos NV(GLPG) | SPONSORED ADR | 36315X101 | $5.3K | 123,300 | 0.0% |
| Sanofi(SNY) | SPONSORED ADR | 80105N105 | $5.5K | 143,500 | 0.0% |
| Vera Therapeutics(VERA) | CL A | 92337R101 | $6.0K | 281,257 | 0.0% |
| Chinook Therapeutics(290A) | COM | 16961L106 | $6.7K | 340,389 | 0.0% |
| Ultragenyx Pharm.(RARE) | COM | 90400D108 | $7.2K | 174,052 | 0.0% |
| Regeneron Pharms.(REGN) | COM | 75886F107 | $7.7K | 11,200 | 0.0% |
| Exelixis Inc(EXEL) | COM | 30161Q104 | $8.5K | 543,000 | 0.0% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $9.5K | 136,000 | 0.0% |
| Supernus Pharms.(SUPN) | COM | 868459108 | $10.1K | 297,500 | 0.0% |
| Uniqure NV(QURE) | SHS | N90064101 | $10.2K | 544,500 | 0.0% |
| Intra-Cellular Therapies(ITCIEUR) | COM | 46116X101 | $10.3K | 221,856 | 0.0% |
| Harmony Biosciences Hldgs(HRMY) | COM | 413197104 | $11.7K | 264,500 | 0.0% |
| Gilead Sciences(GILD) | COM | 375558103 | $12.9K | 208,784 | 0.0% |